Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 96Thoracic 13Gynecologic 10Gastrointestinal 8Dermatologic 6Breast 6Genitourinary 5CNS 3Sarcoma 1Other solid neoplasm 1Other neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Sarcoma 16Ovarian Neoplasms 8Hemangiosarcoma 7Endometrial Neoplasms 7Carcinosarcoma 7Breast Neoplasms 6Sarcoma, Kaposi 4Neoplasms 4Melanoma 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Brain Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Gliosarcoma 3Glioma 3Glioblastoma 3Gastrointestinal Stromal Tumors 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3

Interventions

pembrolizumab 11Nivolumab 4Erlotinib Hydrochloride 3Docetaxel 3Cetuximab 3Capecitabine 3tislelizumab 2spartalizumab 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Gemcitabine 2Filgrastim 2Cyclophosphamide 2tremelimumab 1sargramostim 1ribociclib 1poly ICLC 1pexidartinib 1mirabegron 1futibatinib 1etoposide phosphate 1entinostat 1durvalumab 1ciforadenant 1cemiplimab 1capivasertib 1bempegaldesleukin 1avelumab 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Paclitaxel × Sarcoma × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡